Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Osteoarthritis

Not recruiting

Registered drugNo placebo

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Resiniferatoxin

Contact Research Centre

Acute myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study of Total Body Irradiation and Cladribine Treatment Before Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Cladribine

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Durvalumab with Chemoradiation Therapy for Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Hormone-dependent prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Lung neoplasm malignant

Not recruiting

Registered drug

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Domvanalimab

Contact Research Centre

Non-small cell lung cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Registered drugNo placebo

Poland

Participants:18–64 years
Substances:Acp-017

Contact Research Centre

Chronic graft versus host disease

Not recruiting

Registered drug

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Registered drug

Poland

Participants:0–17 years · 18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Gastric cancer

Not recruiting

Registered drug

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Investigational

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Xevinapant

Contact Research Centre

Gastrooesophageal cancer+5

Not recruiting

Registered drug

Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Find therapies in clinical trials near you – page 10

163 trials match your criteria

Triple negative breast cancer

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Osteoarthritis

Study on the Safety of RTX-GRT7039 and Ropivacaine Hydrochloride Injections for Patients with Moderate to Severe Knee Osteoarthritis Pain

Acute myeloid leukaemia

Study of Total Body Irradiation and Cladribine Treatment Before Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes

Non-small cell lung cancer

Study of Durvalumab with Chemoradiation Therapy for Patients with Unresectable, Locally Advanced Non-small Cell Lung Cancer

Hormone-dependent prostate cancer

Study Comparing 177Lu-PSMA-617 with Standard Treatment for Men with Metastatic Hormone-Sensitive Prostate Cancer

Lung neoplasm malignant

Study on Durvalumab and Domvanalimab for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

Non-small cell lung cancer metastatic

Study Comparing MK-2870 with Chemotherapy (Docetaxel or Pemetrexed) for Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutations

Squamous cell carcinoma of head and neck

Study of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer

Chronic graft versus host disease

Study of Belumosudil and Prednisone for Patients Aged 12 and Older with Newly Diagnosed Chronic Graft Versus Host Disease

Gastric cancer

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Squamous cell carcinoma of head and neck

Study on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin

Gastrooesophageal cancer+5

Study of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.